Friday, January 16, 2026 | 03:31 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 2 - Aurobindo Pharma Ltd News

Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue

Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT due to lower API sales and US market revenue, while its European and growth markets continue to show positive momentum

Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue
Updated On : 05 Aug 2025 | 12:11 AM IST

Aurobindo Pharma Q1 results: Profit drops 10% to ₹824 crore on US sales

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter, hit by dip in sales in the US and API business vertical. The Hyderabad-based drug maker posted a net profit of Rs 918 crore for the April-June quarter of last fiscal. Revenue from operations increased to Rs 7,868 crore for the June quarter as against Rs 7,567 crore in the year-ago period, Aurobindo Pharma said in a regulatory filing. "We started the year steadily, with our European business maintaining strong growth momentum and our core US business showing resilience despite temporary challenges from destocking and seasonal dynamics," K Nithyananda Reddy, Vice-Chairman and Managing Director of the company said. The company's disciplined execution, operational initiatives, and recent US acquisition strengthens commercial footprint and accelerates growth potential, he added. The board of directors at its meeting held on Monday has approved the payment of ..

Aurobindo Pharma Q1 results: Profit drops 10% to ₹824 crore on US sales
Updated On : 04 Aug 2025 | 9:03 PM IST

Q1 results today: Shree Cement, Aurobindo Pharma, DLF, 103 others on Aug 4

Q1 FY26 company results, Aug 4: Marico, Aditya Birla Capital, Ather Energy, Bosch, Delta Corp, Siemens Energy India, Godfrey Phillips, and Inox India will release their April-June quarter report

Q1 results today: Shree Cement, Aurobindo Pharma, DLF, 103 others on Aug 4
Updated On : 04 Aug 2025 | 8:48 AM IST

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Trump on Wednesday called India's tariffs on US exports among the highest in the world, with the most strenuous non-monetary trade barriers of any country, in a post on Truth Social

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs
Updated On : 30 Jul 2025 | 11:20 PM IST